Newbury Pharmaceuticals AB
A hybrid pharmaceutical company focused on specialty drugs in the Nordic region.
NEWBRY | ST
Overview
Corporate Details
- ISIN(s):
- SE0015244884
- LEI:
- 549300F7XHU3I8CWL373
- Country:
- Sweden
- Address:
- Medicon Village, 223 81 Lund
- Website:
- https://www.newburypharma.com/
- Sector:
- Manufacturing
Description
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company focused on specialty prescription drugs and branded medicines. The company's business model combines the capabilities of a marketing authorization holder with those of a specialized commercial partner. It builds its portfolio through global partnerships, in-licensing products, and acting as an exclusive distributor and local representative for other brands. The primary market focus is the Nordic region, with selective international sales. The product portfolio covers various therapeutic areas, including oncology and rare diseases. Newbury Pharmaceuticals manages the full commercialization process, including regulatory affairs, market access, supply chain, and marketing, to deliver medicines to patients and healthcare professionals.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-05 13:14 |
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
|
English | 10.7 KB | ||
| 2017-06-29 13:30 |
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
|
English | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Newbury Pharmaceuticals AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-29 | Johan Strömqvist | Other | Sell | 13,564 | 40,692.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 10,400 | 30,888.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 10,200 | 30,804.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,570.50 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Buy | 5,000 | 15,200.00 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 2,436 | 7,332.36 SEK |
| 2025-04-29 | Johan Strömqvist | Other | Sell | 100 | 305.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Buy | 200,000 | 178,000.00 SEK |
| 2024-08-03 | Andreas Hedskog | Other | Other | 200,000 | N/A |
| 2024-01-22 | Alsakali Equity AB | Other | Buy | 4,000 | 18,920.00 SEK |
Peer Companies
